Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Thrixen works in Biotechnology Research, out of Singapore. Ownership is privately held; it publishes at thrixen.com. It holds one address on record, all in Singapore. The record counts 10 people. Tagged rapid diagnostic test, protein engineering and multiplexing. One Singapore registration (UEN) is a confirmed match. The latest round on record is Seed at US$7.0M. The record links eight similar brands, most of them in Biotechnology Research.
UEN202042220H
| THRIXEN PTE. LTD. | UEN 202042220H |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Thrixen is a biotech/Medtech company that aims to revolutionize the diagnostic technology for the detection of biomarkers at the chemistry level to unlock the next generation of diagnostic and health care monitoring tools that are simple and accessible at the point of care/need.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2021 to 2026 |
| Seed · 29 May 2024 | US$ 7.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. THRIXEN PTE. LTD. (UEN 202042220H), high confidence.
The record holds 10 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Singapore only. Primary: 21 Biopolis Rd, Nucleos, 02-03, Singapore 138567.
One round. Latest 29 May 2024: Seed, US$7,000,000, investor 22Health Ventures.
Three tags on the brand's own list, among them Rapid diagnostic test, Protein engineering and Multiplexing.
5 profiles list Thrixen as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. REVIVO BioSystems and ArrowBiome list it back.